Suchergebnisse - "Karampitsakos, Theodoros"

PubPharm (7)

1

Mast-cell expressed membrane protein-1 is expressed in classical monocytes and alveolar macrophages in idiopathic pulmonary fibrosis and regulates cell chemotaxis, adhesion, and migration in a TGFβ-dependent manner

enthalten in: American journal of physiology. Cell physiology | 2024

von Perrot, C. | Karampitsakos, T. | Unterman, A. | +9

UpdateOf: bioRxiv. 2023 Oct 10;:. - PMID 37873485

2

Editorial : Immune-mediated lung injury

enthalten in: Frontiers in medicine | 2023

von Karampitsakos, T. | Spagnolo, P. | Tzouvelekis, A.

3

Lung cancer in patients with idiopathic pulmonary fibrosis : A retrospective multicentre study in Europe

enthalten in: Respirology (Carlton, Vic.) | 2023

von Karampitsakos, T. | Spagnolo, P. | Mogulkoc, N. | +27

CommentIn: Respirology. 2023 Feb;28(2):196-197. - PMID 36509428

4

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis

enthalten in: Frontiers in medicine | 2020

von Tzouvelekis, A. | Karampitsakos, T. | Kourtidou, S. | +6

5

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis

enthalten in: Frontiers in medicine | 2018

von Tzouvelekis, A. | Toonkel, R. | Karampitsakos, T. | +5

6

Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

enthalten in: Frontiers in medicine | 2017

von Tzouvelekis, A. | Karampitsakos, T. | Ntolios, P. | +11

ErratumIn: Front Med (Lausanne). 2018 Jan 24;4:257. - PMID 29393931

7

Corrigendum : Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

enthalten in: Frontiers in medicine | 2017

von Tzouvelekis, A. | Karampitsakos, T. | Ntolios, P. | +11

ErratumFor: Front Med (Lausanne). 2017 Nov 29;4:213. - PMID 29238708

1
[1]